#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA2038927	A	Oral bioavailability in Sprague-Dawley rat at 2 mg/kg	Rattus norvegicus	5		organism-based format	Scientific Literature
2.	ALA2039029	F	Antagonist activity against human EP2 receptor expressed in CHO-K1 cells assessed as inhibition of cAMP production after 4 hrs by FRET signal in LANCE assay	Homo sapiens	1		cell-based format	Scientific Literature
3.	ALA2039030	F	Antagonist activity at EP1 receptor in human U2OS cells expressing Gqi5 assessed as inhibition of PGE2-induced response after 24 hrs by FLIPR assay	Homo sapiens	2		cell-based format	Scientific Literature
4.	ALA2039031	F	Antagonist activity at dog EP3 receptor expressed in human U2OS cells co-expressing Gqi5 assessed as inhibition of PGE2-induced response after 24 hrs by FLIPR assay	Canis lupus familiaris	1		cell-based format	Scientific Literature
5.	ALA2039032	F	Inhibition of GR63799-induced decrease in bladder capacity in conscious spontaneously hypertensive overactive bladder rat model at 3 mg/kg, id	Rattus norvegicus	1		organism-based format	Scientific Literature
6.	ALA2039034	A	Drug metabolism in rat liver S9 fraction assessed as NADPH-dependent glutathione conjugate level at 10 uM after 30 mins by LC-MS/MS analysis	Rattus norvegicus	4		subcellular format	Scientific Literature
7.	ALA2039035	A	Drug metabolism in human liver S9 fraction assessed as NADPH-dependent glutathione conjugate level at 10 uM after 30 mins by LC-MS/MS analysis	Homo sapiens	4		subcellular format	Scientific Literature
8.	ALA2039036	F	Inhibition of GR63799-induced decrease in bladder capacity in conscious spontaneously hypertensive overactive bladder rat model at 0.3 mg/kg, id	Rattus norvegicus	1		organism-based format	Scientific Literature
9.	ALA2039037	F	Inhibition of PGE2-induced decrease in bladder capacity in conscious spontaneously hypertensive overactive bladder rat model at 30 mg/kg, id	Rattus norvegicus	1		organism-based format	Scientific Literature
10.	ALA2039038	F	Inhibition of acetic acid-induced decrease in bladder capacity in conscious spontaneously hypertensive overactive bladder rat model at 30 mg/kg, id	Rattus norvegicus	1		organism-based format	Scientific Literature
11.	ALA2039039	B	Binding affinity to human EP3	Homo sapiens	1		single protein format	Scientific Literature
12.	ALA2039040	A	Half life in Sprague-Dawley rat at 1 mg/kg, iv	Rattus norvegicus	5		organism-based format	Scientific Literature
13.	ALA2039041	A	Clearance in Sprague-Dawley rat at 1 mg/kg, iv and 2 mg/kg, po	Rattus norvegicus	5		organism-based format	Scientific Literature
14.	ALA2039043	F	Inhibition of saline-induced bladder rhythmic contraction in anesthetized iv dosed Sprague-Dawley rat model	Rattus norvegicus	1		organism-based format	Scientific Literature
15.	ALA2039044	F	Inhibition of GR63799-induced decrease in bladder capacity in conscious spontaneously hypertensive overactive bladder rat model at 30 mg/kg, id	Rattus norvegicus	1		organism-based format	Scientific Literature
16.	ALA2039045	F	Antagonist activity at FP receptor in human U2OS cells expressing Gqi5 assessed as inhibition of PGE2-induced response after 48 hrs by FLIPR assay	Homo sapiens	1		cell-based format	Scientific Literature
17.	ALA2039046	B	Binding affinity at human DP receptor	Homo sapiens	1		single protein format	Scientific Literature
18.	ALA2039047	B	Binding affinity at human EP4 receptor	Homo sapiens	1		single protein format	Scientific Literature
19.	ALA2039048	B	Inhibition of COX2 in rat whole blood assessed as decreased PGE2 production	Rattus norvegicus	1		tissue-based format	Scientific Literature
20.	ALA2039049	P	Aqueous solubility of the compound		1		small-molecule physicochemical format	Scientific Literature